Department of Medicine and Surgery, Pediatrics, University of Salerno, 84081 Baronissi, Italy.
World J Gastroenterol. 2013 May 14;19(18):2740-51. doi: 10.3748/wjg.v19.i18.2740.
We aimed to examine the major causes of isolated chronic hypertransaminasemia in asymptomatic children and develop a comprehensive diagnostic flow diagram. A MEDLINE search inclusive of publications throughout August 2012 was performed. We found only a small number of publications that had comprehensively investigated this topic. Consequently, it was difficult to construct a diagnostic flowchart similar to those already available for adults. In children, a "retesting panel" prescription, including gamma-glutamyl transpeptidase and creatine kinase in addition to aminotransferases, is considered a reasonable approach for proficiently confirming the persistence of the abnormality, ruling out cholestatic hepatopathies and myopathies, and guiding the subsequent diagnostic steps. If re-evaluation of physical and historical findings suggests specific etiologies, then these should be evaluated in the initial enzyme retesting panel. A simple multi-step diagnostic algorithm incorporating a large number of possible pediatric scenarios, in addition to the few common to adults, is available. Accurately classifying a child with asymptomatic persistent hypertransaminasemia may be a difficult task, but the results are critical for preventing the progression of an underlying, possibly occult, condition later in childhood or during transition. Given the high benefit/cost ratio of preventing hepatic deterioration, no effort should be spared in diagnosing and properly treating each case of persistent hypertransaminasemia in pediatric patients.
我们旨在探讨无症状儿童孤立性慢性高转氨酶血症的主要病因,并制定全面的诊断流程图。进行了一项包括 2012 年 8 月之前发表的文献的 MEDLINE 检索。我们仅发现少数几篇全面调查这一课题的文献。因此,很难构建类似于已经存在的成人诊断流程图。在儿童中,包括γ-谷氨酰转肽酶和肌酸激酶在内的“重测谱”处方除了氨基转移酶外,被认为是熟练确认异常持续性、排除胆汁淤积性肝疾病和肌病以及指导后续诊断步骤的合理方法。如果重新评估体格检查和病史提示特定病因,则应在初始酶重测谱中评估这些病因。除了成人常见的少数几种情况外,还可以使用一种包含大量可能的儿科情况的简单多步诊断算法。准确分类无症状持续性高转氨酶血症的儿童可能是一项艰巨的任务,但结果对于预防潜在、可能隐匿的疾病在儿童期后期或过渡期间的进展至关重要。鉴于预防肝恶化的高收益/成本比,应不遗余力地诊断和妥善治疗每例儿科持续性高转氨酶血症患者。